Fri, July 10, 2015
Thu, July 9, 2015
Wed, July 8, 2015
Tue, July 7, 2015
Mon, July 6, 2015
Thu, July 2, 2015
Wed, July 1, 2015
Tue, June 30, 2015
Mon, June 29, 2015
Sun, June 28, 2015
Fri, June 26, 2015
Thu, June 25, 2015
Wed, June 24, 2015
Tue, June 23, 2015
Mon, June 22, 2015
Fri, June 19, 2015
Thu, June 18, 2015
Wed, June 17, 2015
Tue, June 16, 2015
Mon, June 15, 2015
Fri, June 12, 2015
Thu, June 11, 2015
Wed, June 10, 2015
Tue, June 9, 2015
Mon, June 8, 2015
Fri, June 5, 2015
Thu, June 4, 2015
Wed, June 3, 2015
Tue, June 2, 2015
Mon, June 1, 2015
Fri, May 29, 2015
Thu, May 28, 2015
Wed, May 27, 2015
Tue, May 26, 2015
Fri, May 22, 2015
Thu, May 21, 2015
Wed, May 20, 2015
Tue, May 19, 2015
Mon, May 18, 2015
Fri, May 15, 2015

Matthew Luchini Maintained (BLUE) at Buy with Increased Target to $239 on, Jun 15th, 2015


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-239-on-jun-15th-2015.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


Matthew Luchini of BMO Capital, Maintained "bluebird bio, Inc." (BLUE) at Buy with Increased Target from $200 to $239 on, Jun 15th, 2015.

Matthew has made no other calls on BLUE in the last 4 months.



There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Jason McCarthy of "Maxim Group" Initiated at Strong Buy and Held Target at $190 on, Wednesday, April 22nd, 2015

Publication Contributing Sources